Kazia Therapeutics (KZIA) Invested Capital (2017 - 2025)
Kazia Therapeutics (KZIA) has disclosed Invested Capital for 6 consecutive years, with -$3.3 million as the latest value for Q2 2025.
- For the quarter ending Q2 2025, Invested Capital fell 205.58% year-over-year to -$3.3 million, compared with a TTM value of -$3.3 million through Jun 2025, down 205.58%, and an annual FY2025 reading of -$3.3 million, down 207.37% over the prior year.
- Invested Capital was -$3.3 million for Q2 2025 at Kazia Therapeutics, down from $3.1 million in the prior quarter.
- Across five years, Invested Capital topped out at $12.0 million in Q2 2022 and bottomed at -$3.3 million in Q2 2025.
- Average Invested Capital over 4 years is $5.3 million, with a median of $6.2 million recorded in 2023.
- The sharpest move saw Invested Capital fell 23.08% in 2023, then plummeted 205.58% in 2025.
- Year by year, Invested Capital stood at $12.0 million in 2022, then dropped by 23.08% to $9.3 million in 2023, then tumbled by 66.24% to $3.1 million in 2024, then tumbled by 205.58% to -$3.3 million in 2025.
- Business Quant data shows Invested Capital for KZIA at -$3.3 million in Q2 2025, $3.1 million in Q2 2024, and $9.3 million in Q2 2023.